Status:
COMPLETED
Evaluation of the Screening Effect of Artificial Intelligence Hand Activity Evaluation System for Cervical Spondylosis
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
10-second G&R Test
Eligibility:
All Genders
40-80 years
Brief Summary
The purpose of this study: 1. Build an artificial intelligence screening tool for cervical spondylosis based on hand function analysis; 2. Verify the accuracy of cervical spondylosis screening tools.
Detailed Description
Cervical spondylotic myelopathy (CSM) has a high incidence in the middle-aged and elderly people. According to clinical research, the surgeon can makes a preliminary assessment of the severity of CSM ...
Eligibility Criteria
Inclusion
- Age between 18-80 years old;
- Patients who have received cervical CT or MR examination within the last month and have been clearly diagnosed or excluded from cervical spondylosis (i.e., those who have been clearly diagnosed before participating in the study);
- People who are willing to participate in the study with CT/MR examination (i.e., those who have not been diagnosed before joining the study).
Exclusion
- Subjects with cervical spondylosis who have been examined but still cannot be definitively diagnosed or ruled out;
- Subjects with definite presence of hand trauma;
- People who do not have access to CT or MR;
- Subjects who did not comply with the examination, were unable to perform neurological assessment, or were unable to fill out questionnaires.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
1380 Patients enrolled
Trial Details
Trial ID
NCT06041542
Start Date
December 1 2020
End Date
December 30 2022
Last Update
September 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China, 510080